How To Overcome Clinical Trial Pushback

Staying the Course: Sustaining Equity in Clinical Trials Amid Headwinds

David Alvaro of Pharma’s Almanac sits down with Javara’s Tegan Mead, Executive Director, Healthcare Alliance for Part 2 of an interview series to discuss some of today’s hot topics, like…

🔸How to build inclusive protocols and why doing so is critical
🔸Why community trust requires long-term commitment and how to make it a reality
🔸The business case for equity and helping ensure progress continues, despite challenges

“We were finally getting some of those FDA guidances in line that were going to mandate changes that would get us in the place we should be, and while that is on pause, the momentum had already shifted. And despite the broader political climate, I’ve been encouraged to see sponsors staying the course. Many are still dedicating resources to inclusive protocols and community engagement.”

Read the full interview with Pharma’s Almanac!

Check out Part 1 here!